Therapeutic uses of bactericidal/permeability increasing protein

Details Therapeutic uses of bactericidal/permeability increasing protein Therapeutic uses of bactericidal/permeability increasing protein

1995-05-05

1998-09-15

Kemmerer, Elizabeth C.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 12, A61K 3802, A61K 3816

Patent

active

058078185

ABSTRACT:
The present invention provides therapeutic methods for treatment of conditions including the neutralization of the anti-coagulant activity of heparin, inhibition of angiogenesis, tumor and endothelial cell proliferation, and treatment of chronic inflammatory diseases by administration of bactericidal/permeability-increasing (BPI) protein products.

REFERENCES:
patent: 5086164 (1992-02-01), Maione et al.
patent: 5112946 (1992-05-01), Maione
patent: 5171739 (1992-12-01), Scott et al.
patent: 5221664 (1993-06-01), Berkowitz et al.
patent: 5420019 (1995-05-01), Theofan et al.
patent: 5639727 (1997-06-01), Little, II
patent: 5652332 (1997-07-01), Little, II
Ginsburg et al. Killing of endothelial cells and release of arachodonic acid. Synergistic effects among hydrogen peroxide, membrane-damaging agents, cationic substances, and proteinases and their modulation by inhibitors. Inflammation. vol. 17, No. 3, pp. 295-319, Jun. 1993.
Nygaard et al. Defensins reduce the barrier integrity of a cultured epithelial monolayer without cytotoxicity. American Journal of Respiratory Cell and Molecular Biology. vol. 8, No. 2, pp. 193-200, Feb. 1993.
Okrent et al. Direct cytotoxicity of polymorphonuclear leukocyte granule proteins to human lung-derived cells and endothelial cells. American Review of Respiratory Disease. vol. 141, No. 1, pp. 179-185, Jan. 1990.
Azizkahan et al., "Mast Cell Heparin Stimulates Migration of Capilary Endothelial Cells in Vitro", J. Exp. Med., 152:931-944 (Oct. 1980).
Castellot et al., "Heparin Protentiation of 3T3-Adipocyte Stimulated Angiogenesis: Mechanism of Action on Endothelial Cells", J. Cell. Phys., 127:328-329 (1986).
Charles et al., "The Three-Dimensional Structure of Bovine Platelet Factor 4 at 3.0 A Resolution", J. Biol. Chem., 264(4):2092-2099 (Feb. 5, 1989).
Cook et al., "Platelet Factor 4 Efficiently Reverses Heparin Anticoagulation in the Rat Without Adverse Effects of Heparin-Protamine Complexes", Circulation, 85(3):1102-1109 (Mar. 1992).
Folkman et al., "Abiogenesis and Inflammation", Inflammation: Basic Principles and Correlates, 2nd Ed., Review Press, Ltd., Chapter 40, pp. 821-839 (1992).
Gallagher, "Heparan Sulphates as Membrane Receptors for the Fibroblast Growth Factors", Eur. J. Clin. Chem. Clin. Biochem., 32(4):239-247 (1994).
Gammon et al., "T Cell Determinant Structure: Cores and Determinant Envelopes in Three Major Mouse Histocompatibility Complex Halotypes", J. Exp. Med., 173:609-617 (Mar. 1991).
Garcia et al., "Repligen IND for Platelet Factor", Bio World Today, p. 5 (Jan. 11, 1983).
Gazzano-Santoro et al., "High Affinity Binding of the Bactericidal/Permeability Increasing Protein and a Recombinant Amino-Terminal Fragment to the Lipid A Region of Lipopolysaccharide",Infect. Immunol., 60(11):4754-4761 (Nov. 1992).
Gray et al., "Cloning of the cDNA of a Human Neutrophil Bactericidal Protein", J. Biol. Chem., 264(16):9505-9509 (Jun. 5, 1989).
Heyderman et al., "Reduction of the Anticoagulant Activity of Glycosaminoglycans on the Surface of the Vascular Endothelium by Endotoxin and Neutrophils: Evaluation by an Amidolytic Assay", Thrombosis Res., 67:677-685 (Apr. 28, 1992).
Hiti-Harper et al., "Platelet Factor 4: An Inhibitor of Collagenase", Science, 199:991-992 (Mar. 3, 1978).
Kaklamanis, "Expiermental Animal ModelsResembling Rheumatoid Arthritis", Clin. Rheumatol., 11(1):41-47 (1992).
Little, "Functional Domains of Recombinant Bactericidal/Permeability Increasing Protein (rBPI.sub.23)", J. Biol. Chem., 269(3):1865-1872 (Jan. 1994).
Maeji et al., "Multi-Pin Peptide Strategy for T Cell Determinant Analysis", J. Immunol. Methods, 134:23-33 (1990).
Maione et al., "Inhibition of Tumor Growth in Mice by an Analogue of Platelet Factor 4 That Lacks Affinity for Heparin and Retains Potent Angiostatic Activity", Cancer Res., 51:2077-2083 (Apr. 15, 1991).
Maione et al., CAS BioTech Updates-Antibody Conjugates, p. 1, 1334, 117:2260303x (Jun. 16, 1992).
Mannion et al., J. Clin. Invest., 85:853-860 (Mar. 1990).
Marra et al., "The Role of Bactericidal/Permeability-Increasing Protein as a Natural Inhibitor of Bacterial Endotoxin", J. Immunol., 148:532-537 (Jan. 15, 1992).
Marra et al., Aug. 23, 1990 (Abstract: WPI Accession No.: 90-274947/36).
Merrifield et al., "Instrument for Automated Synthesis of Peptides", Anal. Chem., 38(13):1905-1914 (Dec. 1966).
Merrifield et al., "Solid Phase Peptide Synthesis", J. Am. Chem. Soc., 85:2149-2154 (Jul. 20, 1963).
Miles et al., "Recombinant Platelet Factor 4 (rPF4) and a Non-Heparin Binding Derivative Inhibit AIDS-Kaposi Sarcoma Derived Cell Lines", VII International Conference on AIDS Held in Florence Italy, Paper 41(8), W.A. 1066 p. 108 (Jun. 16-21, 1991).
Mitchell et al., "Inhibitors of Angiogenesis", Chapter 16, in Annual Reports in Medical Chemistry, vol. 27, Academic Press, Inc. (1992).
Murav'Ev, Ter. Ark., 52(11):126-129 (1980).
Ooi et al., "Endotoxin-Neutralizing Properties of the 25kD N-Terminal Fragment and a Newly Isolated 30 kD C-Terminal Fragment of the 55-60 kD Bactericidal/Permeability-Increasing Protein of Human Neutrophils", J. Exp. Med., 174:649 (1991).
Passaniti et al., Lab. Invest., 67:519-528 (1992).
Peacock et al., "Angiobiogenesis Inhibition Suppresses Collagen Arthritis", J. Exp. Med., 175:1135-1138 (Apr. 1992).
Redini et al., Biochem. J., 252(2):515-519 (1980).
Repligen Corporation, Research in Review, (Spring 1992).
Stuart et al., "Nature and the Specificity of the Immune Response to Collagen-Induced Arthritis in Mice." J. Clin. Invest., 69:673-683 (Mar. 1982).
Takayama et al., "Absence of Lipopolysaccharide in the Lyme Disease Spirochete." Infect. and Immunol., 55(9):2311-2312 (Sep. 1987).
St. Charles et al., The Journal of Biological Chemistry, 264(4):2092-2099 (1989).
Taylor et al., "Protamine in an Inhibitor of Angiogenesis." Nature, 297:307-312 (May 27, 1982).
Tontsch et al., "Isolation, Characterization, and Long-Term Cultivation of Porcine and Murine Cerebral Capillary Endothelial Cells", Microvascular Res., 37:148-161 (1981).
Vogel et al., "Modulation of Endothelial Cell Proliferation, Adhesion, and Motility by Recombinant Heparin-Binding Domain and Synthetic Peptides From the Type I Repeats of Thrombospondin", J. Cellular Biochem., 53:1-11 (1993).
Weiss et al., "Cellular and Subcellular Localization of the Bactericidal/Permeability-Increasing Protein of Neutrophils", Blood, 69(2):652-659 (Feb. 1987).
Weiss et al., J. Biol. Chem., 253(8):2664-2672 (1978).
Weiss et al., "Partial Characterization and Purification of a Rabbit Granulocyte Factor that Increases Permeability of Escheria coli", J. Clin. Invest., 55:33-42 (1975).
Yayon et al., "Cell Surface, Heparin-Like Molecules are Required for Binding of Basic Fibroblast Growth to its High Affinity Receptor", Cell, 64:641-648 (Feb. 22, 1991).
Yong et al., "An Experimental Mouse Model of Yersinia-Induced Reactive Arthritis", Microbial Pathogenesis, 4:305-310 (1988).

Affiliated with

Also associated with

Rating

Therapeutic uses of bactericidal/permeability increasing protein does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic uses of bactericidal/permeability increasing protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic uses of bactericidal/permeability increasing protein will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-86876